Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of interleukin-1 receptor antagonist on insulin secretion in impaired beta-cell function
2010-019660-36Phase 3Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2010
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, single-arm trial of anakinra in Beta-cell dysfunction, prediabetes and impaired fasting glucose (IFG), sponsored by Radboud University Medical Center. Primary endpoint: Insulin secretion. Started Jun 2010; status: completed.
02
Drugs
anakinra
03
Conditions
Beta-cell dysfunctionprediabetesimpaired fasting glucose (IFG)
Beyond the preview
Go deeper on 2010-019660-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019660-36.